Medicus Pharma Ltd. Files November 2024 6-K Report
Ticker: MDCXW · Form: 6-K · Filed: Nov 18, 2024 · CIK: 1997296
Sentiment: neutral
Topics: reporting, foreign-private-issuer
TL;DR
Medicus Pharma filed its monthly 6-K report on Nov 18th, standard update from Toronto HQ.
AI Summary
Medicus Pharma Ltd. filed a Form 6-K on November 18, 2024, reporting for the month of November 2024. The filing indicates the company's principal executive office is located at Suite 3400, 100 King St W, Toronto, Ontario, Canada. The report was signed by Dr. Raza Bokhari, Executive Chairman and Chief Executive Officer, on November 15, 2024.
Why It Matters
This filing serves as an update for investors and the market regarding Medicus Pharma Ltd.'s ongoing reporting requirements as a foreign private issuer.
Risk Assessment
Risk Level: low — This filing is a routine report of foreign private issuer and does not contain significant new financial or operational information.
Key Players & Entities
- Medicus Pharma Ltd. (company) — Registrant
- Dr. Raza Bokhari (person) — Executive Chairman and Chief Executive Officer
- November 15, 2024 (date) — Date of signature
- November 18, 2024 (date) — Filing date
- Toronto, Ontario, Canada (location) — Principal executive office location
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information that the registrant makes or is required to make public in its home country, files or is required to file with a stock exchange, or distributes or is required to distribute to its security holders.
Who signed the Form 6-K filing on behalf of Medicus Pharma Ltd.?
The Form 6-K was signed by Dr. Raza Bokhari, Executive Chairman and Chief Executive Officer.
On what date was the Form 6-K filed?
The Form 6-K was filed on November 18, 2024.
Where is Medicus Pharma Ltd.'s principal executive office located?
Medicus Pharma Ltd.'s principal executive office is located at Suite 3400, 100 King St W, Toronto, Ontario, Canada.
Does Medicus Pharma Ltd. file annual reports under Form 20-F or Form 40-F?
The filing indicates that Medicus Pharma Ltd. files annual reports under Form 20-F.
Filing Stats: 182 words · 1 min read · ~1 pages · Grade level 9.4 · Accepted 2024-11-15 18:40:52
Filing Documents
- form6k.htm (6-K) — 8KB
- exhibit99-1.htm (EX-99.1) — 9KB
- exhibit99-2.htm (EX-99.2) — 8KB
- exhibit99-3.htm (EX-99.3) — 81KB
- exhibit99-4.htm (EX-99.4) — 77KB
- exhibit99-1x001.jpg (GRAPHIC) — 10KB
- exhibit99-2x001.jpg (GRAPHIC) — 10KB
- 0001062993-24-019231.txt ( ) — 211KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Equinox Gold Corp. Date: November 15, 2024 By /s/ Raza Bokhari Name: Dr. Raza Bokhari Title: Executive Chairman and Chief Executive Officer INDEX TO EXHIBITS Exhibit Description 99.1 Press release, dated November 13, 2024 99.2 Press release, dated November 15, 2024 99.3 Warrant Agency Agreement, dated November 15, 2024 99.4 Common Share Purchase Warrant